US EditionHuge shortfall in NHS funding for weight-loss jab
Funding for the Mounjaro weight-loss jab covers fewer than 50% of eligible patients in many Integrated Care Boards, limiting access despite NHS estimates of 220,000 eligible individuals.
- NHS England began a phased rollout of tirzepatide injections for obesity on 23 June 2025 across England's 40 Integrated Care Boards .
- This rollout follows NHS and NICE guidance but faces significant funding shortfalls, with many ICBs unable to cover all eligible patients, causing local variations.
- Only nine ICBs reported funding to treat 70% of eligible patients, while four ICBs covered just 25% or fewer, including Coventry and Warwickshire at 21% coverage.
- Dr Jonathan Hazlehurst said NHS England funded just over 22,000 patients in year one, about 10% of the 220,000 expected eligible patients, and warned of a lack of political will.
- Experts warn funding gaps and poor communication cause patient and primary care distress, resulting in a postcode lottery and potential tightening of prescribing criteria.
Insights by Ground AI
Does this summary seem wrong?
4 Articles
4 Articles
Sky News UKReposted by 
khbrknews
khbrknewsRevealed: Huge shortfall in NHS funding for weight-loss jab
New research reveals only one in five eligible patients may receive treatment as local NHS budgets fail to meet demand, sparking concerns over a postcode lottery and rationed care.
·United Kingdom
Read Full Article
Revealed: Huge Shortfall In NHS Funding For Weight-loss Jab - Great Yorkshire Radio
The NHS estimates that around 220,000 people living with obesity will be eligible for treatment through their GP over the next three years. But Freedom of Information requests by the British Medical Journal revealed that funding from NHS England has fallen well short of what is needed for the rollout. Just nine out of 40 Integrated Care Boards (ICBs) in England said they had enough funding to treat the 70% of eligible patients who are expected t…
Coverage Details
Total News Sources4
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
